Endocardial fibroelastosis: Difference between revisions
CSV import Tag: Reverted |
CSV import Tags: mobile edit mobile web edit |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Endocardial fibroelastosis | |||
| synonyms = EFE | |||
| field = [[Cardiology]] | |||
| symptoms = [[Heart failure]], [[dyspnea]], [[cyanosis]], [[tachycardia]] | |||
| complications = [[Heart failure]], [[arrhythmia]] | |||
| onset = Usually in infancy | |||
| duration = Chronic | |||
| causes = Often unknown, can be associated with [[viral infection]] or [[genetic disorder]] | |||
| risks = [[Congenital heart defect]], [[family history]] | |||
| diagnosis = [[Echocardiography]], [[chest X-ray]], [[MRI]] | |||
| differential = [[Dilated cardiomyopathy]], [[restrictive cardiomyopathy]] | |||
| treatment = [[Diuretics]], [[ACE inhibitors]], [[beta blockers]], [[heart transplant]] | |||
| prognosis = Variable, often poor without treatment | |||
| frequency = Rare | |||
}} | |||
'''Endocardial Fibroelastosis''' is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications. | '''Endocardial Fibroelastosis''' is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications. | ||
== Causes == | == Causes == | ||
The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications. | The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications. | ||
== Symptoms == | == Symptoms == | ||
Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include: | Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include: | ||
| Line 10: | Line 25: | ||
* Rapid heartbeat | * Rapid heartbeat | ||
* Swelling in the legs, ankles, and feet | * Swelling in the legs, ankles, and feet | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an [[Echocardiogram]], [[Electrocardiogram]], and [[Cardiac MRI]]. | Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an [[Echocardiogram]], [[Electrocardiogram]], and [[Cardiac MRI]]. | ||
== Treatment == | == Treatment == | ||
Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a [[Heart transplant]] may be necessary. | Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a [[Heart transplant]] may be necessary. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life. | The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life. | ||
== See also == | == See also == | ||
* [[Cardiomyopathy]] | * [[Cardiomyopathy]] | ||
* [[Heart failure]] | * [[Heart failure]] | ||
* [[Pediatric cardiology]] | * [[Pediatric cardiology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 03:50, 4 April 2025
| Endocardial fibroelastosis | |
|---|---|
| Synonyms | EFE |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Heart failure, dyspnea, cyanosis, tachycardia |
| Complications | Heart failure, arrhythmia |
| Onset | Usually in infancy |
| Duration | Chronic |
| Types | N/A |
| Causes | Often unknown, can be associated with viral infection or genetic disorder |
| Risks | Congenital heart defect, family history |
| Diagnosis | Echocardiography, chest X-ray, MRI |
| Differential diagnosis | Dilated cardiomyopathy, restrictive cardiomyopathy |
| Prevention | N/A |
| Treatment | Diuretics, ACE inhibitors, beta blockers, heart transplant |
| Medication | N/A |
| Prognosis | Variable, often poor without treatment |
| Frequency | Rare |
| Deaths | N/A |
Endocardial Fibroelastosis is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications.
Causes[edit]
The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications.
Symptoms[edit]
Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include:
- Shortness of breath
- Fatigue
- Rapid heartbeat
- Swelling in the legs, ankles, and feet
Diagnosis[edit]
Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an Echocardiogram, Electrocardiogram, and Cardiac MRI.
Treatment[edit]
Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a Heart transplant may be necessary.
Prognosis[edit]
The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life.
